+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 50Years - 80Years
All Genders
ID06996652

Exploring Adalimumab to Prevent Neurodegeneration in REM Sleep Behavior Disorder A Randomized Placebo-Controlled Trial

Led by Yale University · Updated on 2026-10-30

108

Participants Needed

18

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating adalimumab compared to placebo to see if it can reduce or prevent the progression of synuclein-related neurodegeneration in people with idiopathic REM Sleep Behavior Disorder RBD. This phase 2 study focuses on changes in Parkinson Disease Related Pattern PDRP expression measured by 18-flurodeoxyglucose FDG PET imaging. The study also monitors safety and clinical effects over time. Participants will be randomly assigned to receive either adalimumab or a matching placebo every two weeks for up to two years. After a 12-week screening period, clinic visits occur at 4, 12, and 24 weeks post-dose, then approximately every 24 weeks up to 96 weeks. A safety follow-up visit is scheduled 70 days after the last dose. A subgroup will participate in a cerebrospinal fluid biomarker sub-study involving lumbar punctures at baseline and yearly intervals. Throughout the study, participants will undergo safety monitoring, clinical and biomarker assessments, and quantitative motor and cognitive tests, some completed at home. They will also wear a body sensor for 7 days every 6 months to record sleep and activity patterns. The main outcome is the change in PDRP expression at baseline and week 96, with secondary outcomes including adverse events, lab abnormalities, and clinical progression related to Parkinsons disease and similar conditions.

CONDITIONS

Brief Title

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

Research Team

E

Erika Renkl

K

Kathy Gerich

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here